Access our full analysis report here, it’s free. Therapeutics company Gilead Sciences (NASDAQ:GILD) jumped 7.5%. Is now the time to buy Gilead Sciences? Access our full analysis report here ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ ...

Is now the time to buy Biogen? Access our full analysis report here, it’s free. Therapeutics company Gilead Sciences (NASDAQ:GILD) jumped 7.5%. Is now the time to buy Gilead Sciences? Access our full ...

--Down 10.94% from its 52-week closing high of $117.41 on March 7, 2025 --Up 65.58% from its 52-week closing low of $63.15 on June 18, 2024 --Traded as high as $104.65; highest intraday level ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Co., Gilead Sciences, Inc. and Eaton Corp. plc, as well as a micro-cap stock Maui Land ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands ...

Parsippany Hills (5-12) led 2-1 at the end of the first inning before Morristown (13-8) tied things up in the third. Jordan Ledesma went 2-for-4 with a run for Parsippany Hills.

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...